Skip to main content

Table 3 Treatment and outcomes

From: In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement

  Isolated pleurisy group (N = 51) Pleuro-pulmonary group (N = 154) p value
Anti-tuberculous treatment 46 (90%) 130 (84%) 0.305
Tube thoracostomy or decortication 4 (8%) 24 (16%) 0.163
Days-to-treatment 6 [26.8] 9 [15.6] 0.367
   Within 2 weeks 35 (69%) 86 (56%) 0.264
   More than 2 weeks 11 (21%) 44 (28%)  
   Not treated 5 (10%) 24 (16%)  
Residual pleura thickening*    
   ≥ 10 mm 10 (29%) 24 (35%) 0.542
   < 10 mm 25 (71%) 45 (65%)  
In-hospital mortality rate 2 (4%) 37 (24%) 0.001
Length of hospital stay: days 22 [20.8] 33 [27.9] 0.003
  1. Data are no. (%) or mean [SD]
  2. * After six months of anti-tuberculous treatment, only 36 patients in the isolated pleurisy group and 72 in the pleuro-pulmonary group were still being followed in our hospital.